Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,988,249 | 2,791,723 | 3,182,715 | 3,046,604 | 3,607,513 |
| Marketable Securities | 119,470 | 178,342 | 236,070 | 361,907 | 545,163 |
| Receivables | 2,855,217 | 3,150,407 | 2,953,246 | 2,986,768 | 3,092,553 |
| Inventories | 1,342,035 | 1,218,823 | 1,304,891 | 1,293,033 | 1,427,854 |
| Other current assets | 144,586 | 140,105 | 142,401 | 144,582 | 117,135 |
| TOTAL | $7,449,557 | $7,479,400 | $7,819,323 | $7,832,894 | $8,790,218 |
| Non-Current Assets | |||||
| PPE Net | 1,667,927 | 1,659,942 | 1,670,406 | 1,685,264 | 1,846,108 |
| Investments And Advances | 762,430 | 883,673 | 776,770 | 869,922 | 1,020,092 |
| Intangibles | 4,065,855 | 3,842,520 | 3,458,391 | 3,502,786 | 3,932,847 |
| Other Non-Current Assets | 988,728 | 794,425 | 794,678 | 705,158 | 732,295 |
| TOTAL | $7,484,940 | $7,180,560 | $6,700,245 | $6,763,130 | $7,531,342 |
| Total Assets | $14,934,510 | $14,659,980 | $14,519,560 | $14,596,020 | $16,321,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,506,940 | 1,632,989 | 1,656,572 | 1,636,007 | 2,062,078 |
| Other current liabilities | 1,751,167 | 1,475,574 | 1,423,676 | 1,490,621 | 1,627,317 |
| TOTAL | $3,430,880 | $3,359,048 | $3,240,845 | $3,208,045 | $3,830,099 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,046,198 | 451,877 | 422,890 | 444,251 | 492,383 |
| TOTAL | $1,052,191 | $458,118 | $429,368 | $450,852 | $498,425 |
| Total Liabilities | $4,483,071 | $3,817,166 | $3,670,213 | $3,658,897 | $4,328,524 |
| Shareholders' Equity | |||||
| Common Shares | 854,908 | 844,608 | 844,608 | 844,608 | 937,309 |
| Retained earnings | 8,076,348 | 7,813,206 | 7,586,755 | 7,103,291 | 8,236,255 |
| Other shareholders' equity | 1,355,879 | 1,799,678 | 1,803,948 | 2,017,291 | 2,002,396 |
| TOTAL | $10,451,430 | $10,842,810 | $10,849,350 | $10,937,130 | $11,993,040 |
| Total Liabilities And Equity | $14,934,501 | $14,659,976 | $14,519,563 | $14,596,027 | $16,321,564 |